Press Releases about Gilead Sciences
![](https://mms.businesswire.com/media/20221207005859/en/1658577/5/DaiichiSankyoLogo.jpg)
![](https://mms.businesswire.com/media/20221205005862/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20221128005858/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20221128005232/en/1647678/5/ARCUS_Logo_RGB_1920x1080.jpg)
![](https://mms.businesswire.com/media/20221115005033/en/778437/5/GCP_Primarylarge_1.jpg)
Gilead Sciences to Present at Upcoming Investor Conferences
November 15, 2022
Via Business Wire
![](https://www.marketbeat.com/logos/articles/small_stock-image_20038039_S.jpg)
![](https://mms.businesswire.com/media/20221103005748/en/1624483/4/JointLogo.jpg)
![](https://mms.businesswire.com/media/20221102005034/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20221031005390/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20221026006084/en/778437/5/GCP_Primarylarge_1.jpg)
Gilead Sciences Announces Third Quarter 2022 Financial Results
October 27, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221023005062/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20221020005633/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20221017005765/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20221017005912/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20221016005052/en/1603368/5/MacroGenics_Logo.jpg)
![](https://mms.businesswire.com/media/20221013005169/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20221010005766/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20221003005550/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20220921005778/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20220919005772/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Gilead Sciences Completes Acquisition of MiroBio
September 20, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220916005209/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20220915006144/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20220915005509/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20220912005885/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20220906006036/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20220906006101/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20220902005309/en/778437/5/GCP_Primarylarge_%281%29.jpg)
![](https://mms.businesswire.com/media/20220829005663/en/778437/5/GCP_Primarylarge_%281%29.jpg)
Gilead Sciences to Present at Upcoming Investor Conferences
August 29, 2022
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.